Abstract
In this paper I will attempt to outline what I believe to be the most persuasive and acceptable (although not necessarily as yet accepted) theoretical justifications for the widest possible access to medicines and for prioritising measures to increase this access. This paper sets out the compelling arguments for state responsibility for these matters independently of any private or commercial arrangements that may be in place.
Keywords: Fairness, Hobbes, Just Distribution, Justice, Safety of the people.
Reviews on Recent Clinical Trials
Title:Access to Medicines and the Safety of the People
Volume: 10 Issue: 1
Author(s): John Harris
Affiliation:
Keywords: Fairness, Hobbes, Just Distribution, Justice, Safety of the people.
Abstract: In this paper I will attempt to outline what I believe to be the most persuasive and acceptable (although not necessarily as yet accepted) theoretical justifications for the widest possible access to medicines and for prioritising measures to increase this access. This paper sets out the compelling arguments for state responsibility for these matters independently of any private or commercial arrangements that may be in place.
Export Options
About this article
Cite this article as:
Harris John, Access to Medicines and the Safety of the People, Reviews on Recent Clinical Trials 2015; 10 (1) . https://dx.doi.org/10.2174/1574887110666150430152618
DOI https://dx.doi.org/10.2174/1574887110666150430152618 |
Print ISSN 1574-8871 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-1038 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Clinical Application of Ghrelin
Current Pharmaceutical Design Moderate Wine Consumption in the Prevention of Metabolic Syndrome and its Related Medical Complications
Endocrine, Metabolic & Immune Disorders - Drug Targets TNF alpha Inhibition as Treatment Modality for Certain Rheumatologic and Gastrointestinal Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Aldose Reductase in Diabetic Microvascular Complications
Current Drug Targets Mitochondrial Targeting for Development of Novel Drug Strategies in Brain Injury
Central Nervous System Agents in Medicinal Chemistry Epidemiology and Costs of Hypertension-related Disorders
Current Pharmaceutical Design Efficacy and Safety Outcomes of Short Duration Antiplatelet Therapy with Early Cessation of Aspirin Post Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis
Current Cardiology Reviews The Fibroblast Growth Factor 23: A New Player in the Field of Cardiovascular, Bone and Renal Disease
Current Vascular Pharmacology Emerging Anticoagulant Therapies for Atrial Fibrillation: New Options, New Challenges
Current Medicinal Chemistry Physical Activity and Hypertension: Evidence of Cross-Sectional Studies,Cohort Studies and Meta-Analysis
Current Hypertension Reviews Small-Molecules Targeting Kinases Involved in Pulmonary Hypertension: a Patent Review (2010-2015)
Current Medicinal Chemistry Cardiac Remodeling and Exercise Training in Hypertension
Current Hypertension Reviews New Aspects of Statin Safety
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Preclinical Testing of Drug-Induced Proarrhythmia: Value of Transgenic Models
Cardiovascular & Hematological Agents in Medicinal Chemistry Antiprotozoal Agents: An Overview
Anti-Infective Agents in Medicinal Chemistry Milestones in Antihypertensive Drug Treatment
Current Pharmaceutical Design Sirolimus and its Analogs and its Effects on Vascular Diseases
Current Pharmaceutical Design Olive Oil and Apoptosis of Cancer Cells
Current Nutrition & Food Science Comparative Effect of Telmisartan vs Lisinopril on Blood Pressure in Patients of Metabolic Syndrome
Endocrine, Metabolic & Immune Disorders - Drug Targets Energy Balance and Carcinogenesis: Underlying Pathways and Targets for Intervention
Current Cancer Drug Targets